Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-14 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −1,395 $7.76 $11K 27,213
2023-07-14 BILINSKY IGOR Chief Operating Officer Option exercise · Restricted Stock Units −2,813 16,877
2023-06-06 Countouriotis Athena Director Grant or award · Deferred Restricted Stock Unit +51,955 51,955
2023-06-06 MCPEAK MERRILL A Director Grant or award · Deferred Restricted Stock Unit +51,955 51,955
2023-06-06 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +51,955 51,955
2023-06-06 WEISER MICHAEL Director Grant or award · Deferred Restricted Stock Unit +51,955 51,955
2023-06-06 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +103,911 103,911
2023-06-06 YARNO WENDY L Director Grant or award · Deferred Restricted Stock Unit +12,988 12,988
2023-04-18 YARNO WENDY L Director Grant or award · Deferred Restricted Stock Unit +74,823 74,823
2023-04-14 Vogt Frederick G Interim CEO & General Counsel Option exercise +20,834 69,718
2023-04-14 Vogt Frederick G Interim CEO & General Counsel Shares withheld for taxes −8,851 $5.64 $50K 60,867
2023-04-14 Vogt Frederick G Interim CEO & General Counsel Option exercise · Restricted Stock Units −20,834 145,841
2023-04-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise +2,812 30,930
2023-04-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Shares withheld for taxes −1,395 $5.64 $8K 29,535
2023-04-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Option exercise · Restricted Stock Units −2,812 19,690
2023-04-14 BILINSKY IGOR Chief Operating Officer Option exercise +2,812 27,190
2023-04-14 BILINSKY IGOR Chief Operating Officer Shares withheld for taxes −1,395 $5.64 $8K 25,795
2023-04-14 BILINSKY IGOR Chief Operating Officer Option exercise · Restricted Stock Units −2,812 19,690
2023-03-02 Vogt Frederick G See Remarks Grant or award · Restricted Stock Units +125,000 125,000
2023-03-02 Vogt Frederick G See Remarks Grant or award · Stock Option (right to buy) +500,000 500,000

Page 18 of 23 · 446 trades